Clonal Hematopoiesis: The Emergent CVD Risk Factor.
作者信息
Cochran Jesse D, Walsh Kenneth
机构信息
Hematovascular Biology Center, Division of Cardiovascular Medicine and Robert M. Berne Cardiovascular Research Center (J.D.C., K.W.), University of Virginia School of Medicine, Charlottesville.
Medical Scientist Training Program (J.D.C.), University of Virginia School of Medicine, Charlottesville.
出版信息
Arterioscler Thromb Vasc Biol. 2024 Apr;44(4):768-771. doi: 10.1161/ATVBAHA.123.319562. Epub 2024 Mar 27.
Abstract
摘要
相似文献
1
Clonal Hematopoiesis: The Emergent CVD Risk Factor.克隆性造血：新出现的心血管疾病风险因素。
Arterioscler Thromb Vasc Biol. 2024 Apr;44(4):768-771. doi: 10.1161/ATVBAHA.123.319562. Epub 2024 Mar 27.
2
Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.克隆性造血与心血管疾病：JAK2V617F 的作用。
J Cardiol. 2023 Jan;81(1):3-9. doi: 10.1016/j.jjcc.2022.02.001. Epub 2022 Feb 12.
3
Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions.克隆性造血不定潜能与心血管疾病：发病机制、临床表现及未来方向。
Prog Cardiovasc Dis. 2024 Sep-Oct;86:79-85. doi: 10.1016/j.pcad.2024.09.001. Epub 2024 Sep 14.
4
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV.携带 HIV 人群中的克隆性造血对心血管疾病的影响。
Exp Hematol. 2022 Oct;114:18-21. doi: 10.1016/j.exphem.2022.07.304. Epub 2022 Aug 6.
5
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review.克隆性造血、心血管疾病和癌症之间的联系：综述。
JAMA Cardiol. 2019 Apr 1;4(4):380-387. doi: 10.1001/jamacardio.2019.0302.
6
Clonal Hematopoiesis: From Macrovascular to Microvascular Disease.克隆性造血：从大血管疾病到微血管疾病
Arterioscler Thromb Vasc Biol. 2023 May;43(5):784-786. doi: 10.1161/ATVBAHA.123.319197. Epub 2023 Mar 23.
7
[Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?].[克隆性造血：白血病和心血管疾病的危险因素？]
Ned Tijdschr Geneeskd. 2020 Nov 5;164:D5205.
8
Genomic Aging, Clonal Hematopoiesis, and Cardiovascular Disease.基因组衰老、克隆性造血与心血管疾病
Arterioscler Thromb Vasc Biol. 2023 Jan;43(1):3-14. doi: 10.1161/ATVBAHA.122.318181. Epub 2022 Nov 10.
9
Clonal Hematopoiesis in Patients With Atherosclerotic Cardiovascular Disease: One Step Closer to the Clinical Scenario.动脉粥样硬化性心血管疾病患者的克隆性造血：向临床应用迈进了一步。
J Am Coll Cardiol. 2023 May 23;81(20):2010-2012. doi: 10.1016/j.jacc.2023.03.420.
10
Clonal hematopoiesis of indeterminate potential and cardiovascular disease.意义未明的克隆性造血与心血管疾病
Transl Res. 2023 May;255:152-158. doi: 10.1016/j.trsl.2022.08.013. Epub 2022 Sep 5.
引用本文的文献
1
Multi-Cohort Analysis Reveals Genetic Predispositions to Clonal Hematopoiesis as Mutation-Specific Risk Factors for Stroke.多队列分析揭示克隆性造血的遗传易感性是中风的特定突变风险因素。
Adv Genet (Hoboken). 2025 Feb 8;6(1):2400047. doi: 10.1002/ggn2.202400047. eCollection 2025 Mar.
2
Clonal Hematopoiesis Is Associated With Adverse Clinical Outcomes and Left Ventricular Remodeling in Aortic Stenosis.克隆性造血与主动脉瓣狭窄的不良临床结局及左心室重塑相关。
JACC Adv. 2025 Jan 8;4(2):101532. doi: 10.1016/j.jacadv.2024.101532. eCollection 2025 Feb.
本文引用的文献
1
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.克隆性造血在射血分数保留的临床和实验性心力衰竭中的作用
Circulation. 2023 Oct 10;148(15):1165-1178. doi: 10.1161/CIRCULATIONAHA.123.064170. Epub 2023 Sep 8.
2
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.不定潜能克隆性造血预测动脉粥样硬化性心血管疾病患者的不良结局。
J Am Coll Cardiol. 2023 May 23;81(20):1996-2009. doi: 10.1016/j.jacc.2023.03.401.
3
Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease.不确定潜能的克隆性造血与早期非阻塞性冠状动脉疾病中的冠状动脉微血管功能障碍相关。
Arterioscler Thromb Vasc Biol. 2023 May;43(5):774-783. doi: 10.1161/ATVBAHA.122.318928. Epub 2023 Mar 23.
4
Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke.克隆性造血与首发缺血性脑卒中患者再发血管事件和死亡的相关性。
Blood. 2023 Feb 16;141(7):787-799. doi: 10.1182/blood.2022017661.
5
Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction.导致心肌梗死后并发心源性休克的克隆性造血的影响。
J Am Coll Cardiol. 2022 Oct 18;80(16):1545-1556. doi: 10.1016/j.jacc.2022.08.740.
6
Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers.克隆性造血不定潜能：与心力衰竭发生率、临床参数和生物标志物的关联。
Eur J Heart Fail. 2023 Jan;25(1):4-13. doi: 10.1002/ejhf.2715. Epub 2022 Oct 25.
7
Clonal hematopoiesis, somatic mosaicism, and age-associated disease.克隆性造血、体细胞镶嵌性和与年龄相关的疾病。
Physiol Rev. 2023 Jan 1;103(1):649-716. doi: 10.1152/physrev.00004.2022. Epub 2022 Sep 1.
8
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.TET2 驱动的克隆性造血与卡那奴单抗反应：CANTOS 随机临床试验的探索性分析。
JAMA Cardiol. 2022 May 1;7(5):521-528. doi: 10.1001/jamacardio.2022.0386.
9
Targeting the NLRP3 inflammasome in cardiovascular diseases.针对心血管疾病中的 NLRP3 炎性小体。
Pharmacol Ther. 2022 Aug;236:108053. doi: 10.1016/j.pharmthera.2021.108053. Epub 2021 Dec 11.
10
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke.克隆性造血与更高的中风风险相关。
Stroke. 2022 Mar;53(3):788-797. doi: 10.1161/STROKEAHA.121.037388. Epub 2021 Nov 8.
Zotero 插件